Literature DB >> 21901350

Scleroderma pattern of nailfold capillary changes as predictive value for the development of a connective tissue disease: a follow-up study of 3,029 patients with primary Raynaud's phenomenon.

Slavica Pavlov-Dolijanovic1, Nemanja S Damjanov, Roksanda M Stojanovic, Nada Z Vujasinovic Stupar, Dejana M Stanisavljevic.   

Abstract

To assess the prognostic value of scleroderma pattern of nailfold capillary changes for the development of connective tissue diseases (CTD) in subjects with primary Raynaud's phenomenon (RP). The study included 3,029 consecutive patients with primary RP who had been followed at 6-month intervals during the mean of 4.8 years. The pathological features of nailfold capillaroscopy were recorded in all patients who had neither clinical nor serological signs of a CTD. In patients who developed CTD, capillary changes obtained 6 months prior to diagnosis were analyzed. A possible relationship between capillary changes and the presence of associated CTD was assessed. At the end of follow-up, 1,660 (54,8%) patients have still the primary RP, 246 (8,1%) had suspected secondary RP, and 1,123 (37,1%) patients developed CTD (363 undifferentiated CTD, 263 systemic sclerosis, 143 systemic lupus erythematosus, 106 rheumatoid arthritis, 102 Sjögren's syndrome, 61 overlap syndrome, 30 vasculitides, 24 mixed CTD, 19 polymyositis, 7 dermatomyositis, and 5 primary antiphospholipid syndrome). Scleroderma pattern were significantly associated with the development of systemic sclerosis [P = .00001, sensitivity 94%, specificity 92%, positive predictive value 52%, negative predictive value 99%, and odds ratio 163 (95% CI, 97,9-271,5)], as well as dermatomyositis (P = .0004), overlap syndrome with signs of systemic sclerosis (P = .0001), and mixed connective tissue disease (P = .007). Capillary microscopy is effective method for differentiation between primary and secondary RP and useful tool for the prediction of scleroderma spectrum disorders in RP patients.

Entities:  

Mesh:

Year:  2011        PMID: 21901350     DOI: 10.1007/s00296-011-2109-2

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  41 in total

Review 1.  Undifferentiated connective tissue diseases (UCTD): a review of the literature and a proposal for preliminary classification criteria.

Authors:  M Mosca; R Neri; S Bombardieri
Journal:  Clin Exp Rheumatol       Date:  1999 Sep-Oct       Impact factor: 4.473

2.  Predictive value of nailfold capillaroscopy in patients with Raynaud's phenomenon.

Authors:  Madeleine Meli; Gabriela Gitzelmann; Renate Koppensteiner; Beatrice R Amann-Vesti
Journal:  Clin Rheumatol       Date:  2005-06-11       Impact factor: 2.980

3.  The predictive value of quantitative nailfold capillary microscopy in patients with undifferentiated connective tissue disease.

Authors:  T Ohtsuka; T Tamura; A Yamakage; S Yamazaki
Journal:  Br J Dermatol       Date:  1998-10       Impact factor: 9.302

4.  Capillaroscopic observations in rheumatic diseases.

Authors:  W Redisch; E J Messina; G Hughes; C McEwen
Journal:  Ann Rheum Dis       Date:  1970-05       Impact factor: 19.103

5.  Significance of anticentromere antibody in idiopathic Raynaud's syndrome.

Authors:  J Sarkozi; A A Bookman; P Lee; E C Keystone; M J Fritzler
Journal:  Am J Med       Date:  1987-11       Impact factor: 4.965

6.  Outcomes in primary Raynaud phenomenon: a meta-analysis of the frequency, rates, and predictors of transition to secondary diseases.

Authors:  G Spencer-Green
Journal:  Arch Intern Med       Date:  1998-03-23

7.  Comparison between 3 diagnostic criteria for mixed connective tissue disease. Study of 593 patients.

Authors:  D Alarcón-Segovia; M H Cardiel
Journal:  J Rheumatol       Date:  1989-03       Impact factor: 4.666

8.  The CREST syndrome: a distinct serologic entity with anticentromere antibodies.

Authors:  M J Fritzler; T D Kinsella
Journal:  Am J Med       Date:  1980-10       Impact factor: 4.965

9.  Prognostic significance of nailfold capillary microscopy in patients with Raynaud's phenomenon and scleroderma-pattern abnormalities. A six-year follow-up study.

Authors:  P Zufferey; M Depairon; A M Chamot; M Monti
Journal:  Clin Rheumatol       Date:  1992-12       Impact factor: 2.980

10.  [Focus on a quick reading of nailfold capillaroscopy].

Authors:  P Jouanny; C Schmidt; L Feldmann; J Schmitt
Journal:  J Mal Vasc       Date:  1994
View more
  22 in total

1.  The value of pattern capillary changes and antibodies to predict the development of systemic sclerosis in patients with primary Raynaud's phenomenon.

Authors:  Slavica R Pavlov-Dolijanovic; Nemanja S Damjanov; Nada Z Vujasinovic Stupar; Snezana Baltic; Dragan D Babic
Journal:  Rheumatol Int       Date:  2013-08-11       Impact factor: 2.631

Review 2.  The impact of anti-U1-RNP positivity: systemic lupus erythematosus versus mixed connective tissue disease.

Authors:  Alina Dima; Ciprian Jurcut; Cristian Baicus
Journal:  Rheumatol Int       Date:  2018-05-23       Impact factor: 2.631

Review 3.  Early systemic sclerosis-opportunities for treatment.

Authors:  Lazaros I Sakkas; Theodora Simopoulou; Christina Katsiari; Dimitrios Bogdanos; Ian C Chikanza
Journal:  Clin Rheumatol       Date:  2015-02-26       Impact factor: 2.980

4.  Pan-American League of Associations for Rheumatology (PANLAR) capillaroscopy study group consensus for the format and content of the report in capillaroscopy in rheumatology.

Authors:  Chiara Bertolazzi; Angélica Vargas Guerrero; Tatiana Sofía Rodríguez-Reyna; Hugo Sandoval; Everardo Álvarez-Hernández; Marcelo José Audisio; Eduardo Cabello; Paola Coral-Alvarado; Ericka Díaz; Virginia Duringan; Karinna Espejo; Selma Gallegos; Gabriela Hernández-Molina; Blanca Herrera; Cristiane Kayser; María Eugenia Lara; Genessis Maldonado; Marta N Mamani; Alejandro Nitsche; Carlos Ríos-Acosta; Félix Enrique-Romanini; María Sormani de Fonseca; Verónica Silva Vilela; Miguel Angel Villarreal-Alarcón; Marwin Gutiérrez
Journal:  Clin Rheumatol       Date:  2019-06-08       Impact factor: 2.980

Review 5.  [Capillaroscopy. An update].

Authors:  J Richter; C Iking-Konert; M Schneider; O Sander
Journal:  Z Rheumatol       Date:  2013-03       Impact factor: 1.372

6.  Successfully treated fingertip necrosis in an infant with primary Raynaud phenomenon.

Authors:  Saliha Senel; Pelin Zorlu; Burcin Dogan; Mehtap Acar
Journal:  Indian J Pediatr       Date:  2014-05-06       Impact factor: 1.967

7.  [Raynaud's phenomenon : Practical management].

Authors:  C Drerup; A Maier; J Ehrchen
Journal:  Z Rheumatol       Date:  2019-12       Impact factor: 1.372

8.  Late appearance and exacerbation of primary Raynaud's phenomenon attacks can predict future development of connective tissue disease: a retrospective chart review of 3,035 patients.

Authors:  Slavica Pavlov-Dolijanovic; Nemanja S Damjanov; Nada Z Vujasinovic Stupar; Goran L Radunovic; Roksanda M Stojanovic; Dragan Babic
Journal:  Rheumatol Int       Date:  2012-07-22       Impact factor: 2.631

9.  Is there a difference in systemic lupus erythematosus with and without Raynaud's phenomenon?

Authors:  Slavica Pavlov-Dolijanovic; Nemanja S Damjanov; Nada Z Vujasinovic Stupar; Danijel R Marcetic; Mirjana N Sefik-Bukilica; Radmila R Petrovic
Journal:  Rheumatol Int       Date:  2012-05-22       Impact factor: 2.631

10.  Anti-nuclear antibodies as predictor of outcome in a multi-center cohort of Italian children and adolescents with Raynaud's phenomenon.

Authors:  Fernanda Falcini; Donato Rigante; Marcello Candelli; Giorgia Martini; Fabrizia Corona; Antonella Petaccia; Francesco La Torre; Carmela G L Raffaele; Marco Matucci Cerinic
Journal:  Clin Rheumatol       Date:  2014-11-28       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.